Remilk’s animal-free dairy products will soon be available in Israel, following the company receiving a first-of-its-kind approval from the Israeli Ministry of Health (MOH).

The B2B precision fermentation company creates dairy products without inputs from animals, and which are free from lactose, cholesterol, antibiotics and growth hormones.

The approval, a first for Israel, follows Remilk also being granted a ‘No Questions Letter’ from the United States’ FDA, as well as regulatory clearance in Singapore.

“This is a defining moment, not only for Remilk, but for the entire global alternative protein industry and the state of Israel, one of the first in the world to recognise the significance of precision fermentation,” said Remilk’s CEO and co-founder, Aviv Wolff. “The opening of the Israeli market to real, animal-free dairy products will place Israel not only at the forefront of global-food tech research and development, but also as a leading market in the world for new food consumption. Today’s news opens the door for the introduction of high quality and nutritious animal-free dairy products.”

Since being founded in 2019, the company has raised more than $130 million, and signed partnerships with leading global food industry players, including a large scale commercial agreement with the Central Bottling Company, the Israeli franchisee of Coca-Cola, to launch a line of dairy products for the Israeli market, using Remilk’s protein.

“The breakthrough achievement of Remilk’s R&D team lies in its success in converting a technology that has been used for decades to create components for the food industry such as vitamins and enzymes in small quantities, to produce one of the most significant and high quality components in the food industry. Our milk protein, produced on an industrial scale, allows us to practically change the face of the dairy market,” said Dr Ori Cohavi, chief technology officer and co-founder of Remilk.

Listen to our podcast episode with Remilk’s head of business development, Jason Rosenberg, below.

To stay up-to-date on the latest industry headlines, sign up to Future Alternative’s enewsletter.

Posted on:

Leave a comment

Your email address will not be published. Required fields are marked *